ASAP will support higher-risk, large-scale, ambitious projects across two tracks: scientific track and technical track.
Scientific: an international, multidisciplinary, multi-institutional network of research teams working to address high-priority research questions in an effort to advance our understanding of Parkinson’s disease (PD) and drive new ideas into the R&D pipeline.
Technical: supporting the development of novel tools that can be reliably produced and shared with the research community to accelerate validation and therapeutic R&D for emerging targets pursued or identified through ASAP discoveries.
Objective: Generate, validate, and distribute preclinical reagents and/or models tailored to support critical research needs for at least 5 targets from a list of eligible targets.
